Skip to main content

Obese Subjects and Supplemental l-Arginine

  • Chapter
  • First Online:
L-Arginine in Clinical Nutrition

Abstract

Obesity and overweight are constantly growing health problems throughout the world. According to the World Health Organization, nearly one billion adults are overweight, and 300 million people are obese (World Health Statistics. http://www.who.int/gho/publications/world_health_statistics/en/. Accessed 12 Apr 2014). Although it is widely accepted that obesity is associated with dyslipidemia, hypertension, atherosclerosis, stroke, insulin resistance, and some types of cancers, pharmacological treatment for this chronic disease is limited. The alarming increase in the occurrence of obesity and overweight has compelled researchers to seek new forms of drug therapy. Emerging evidence from both experimental and clinical studies shows that l-arginine (Arg) holds great promise for the prevention and treatment of adiposity and associated metabolic disorders in humans and animals. An anti-obesity effect of Arg is yet to be demonstrated, and the mechanisms responsible for the beneficial effects of Arg are very complex and involve nitric oxide (NO) signaling, enhancing of mitochondrial biogenesis, growth of brown adipose tissue and stimulation of thermogenesis, regulation of fat metabolic gene expression, and changes in fat tissue endocrine secretion.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. World Health Statistics. http://www.who.int/gho/publications/world_health_statistics/en/. Accessed 12 Apr 2014.

  2. Jobgen WS, Meininger CJ, Jobgen SC, et al. Dietary l-arginine supplementation reduces white fat gain and enhances skeletal muscle and brown fat masses in diet-induced obese rats. J Nutr. 2009;139:230–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. McKnight JR, Satterfield MC, Jobgen WS, et al. Beneficial effects of l-arginine on reducing obesity: potential mechanisms and important implications for human health. Amino Acids. 2010;39:349–57.

    Article  CAS  PubMed  Google Scholar 

  4. Fu WJ, Haynes TE, Kohli R, et al. Dietary l-arginine supplementation reduces fat mass in Zucker diabetic fatty rats. J Nutr. 2005;135:714–21.

    CAS  PubMed  Google Scholar 

  5. Tan B, Yin Y, Liu Z, et al. Dietary l-arginine supplementation differentially regulates expression of lipid-metabolic genes in porcine adipose tissue and skeletal muscle. J Nutr Biochem. 2011;22:441–5.

    Article  CAS  PubMed  Google Scholar 

  6. Wu G, Collins JK, Perkins-Veazie P, et al. Dietary supplementation with watermelon pomace juice enhances l-arginine availability and ameliorates the metabolic syndrome in Zucker diabetic fatty rats. J Nutr. 2007;137:2680–5.

    CAS  PubMed  Google Scholar 

  7. Tan B, Yin Y, Liu Z, et al. Dietary l-arginine supplementation increases muscle gain and reduces body fat mass in growing-finishing pigs. Amino Acids. 2009;37:169–75.

    Article  CAS  PubMed  Google Scholar 

  8. He QH, Kong XF, Wu G, et al. Metabolomic analysis of the response of growing pigs to dietary l-arginine supplementation. Amino Acids. 2009;37:199–208.

    Article  CAS  PubMed  Google Scholar 

  9. Go G, Wu G, Silvey D, et al. Lipid metabolism in pigs fed supplemental conjugated linoleic acid and/or dietary l-arginine. Amino Acids. 2012;43:1713–26.

    Article  CAS  PubMed  Google Scholar 

  10. Bai Y, Sun L, Yang T, et al. Increase in fasting vascular endothelial function after short-term oral l-arginine is effective when baseline flow-mediated dilation is low: a meta-analysis of randomised controlled trials. Am J Clin Nutr. 2009;89:77–84.

    Article  CAS  PubMed  Google Scholar 

  11. van Vught AJ, Heitmann BL, Nieuwenhuizen AG, et al. Association between dietary protein and change in body composition among children (EYHS). Clin Nutr. 2009;28:684–8.

    Article  PubMed  Google Scholar 

  12. Michishita T, Kobayashi S, Katsuya T, et al. Evaluation of the antiobesity effects of an amino acid mixture and conjugated linoleic acid on exercising healthy overweight humans: a randomized, double-blind, placebo-controlled trial. J Int Med Res. 2010;38:844–59.

    Article  CAS  PubMed  Google Scholar 

  13. Lucotti P, Setola E, Monti LD, et al. Beneficial effects of a long-term oral l-arginine treatment added to a hypocaloric diet and exercise training program in obese, insulin-resistant type 2 diabetic patients. Am J Physiol Endocrinol Metab. 2006;291:906–12.

    Article  Google Scholar 

  14. Monti LD, Casiraghi MC, Setola E, Galluccio E, et al. l-arginine enriched biscuits improve endothelial function and glucose metabolism: a pilot study in healthy subjets and a cross-over study in subjects with impaired glucose tolerance and metabolic syndrome. Metabolism. 2013;62:255–64.

    Article  CAS  PubMed  Google Scholar 

  15. Bogdanski P, Suliburska J, Grabanska K, et al. Effect of 3-month l-arginine supplementation on insulin resistance and tumor necrosis factor activity in patients with visceral obesity. Eur Rev Med Pharmacol Sci. 2012;16:816–23.

    CAS  PubMed  Google Scholar 

  16. Suliburska J, Bogdanski P, Szulinska M, et al. Changes in mineral status are associated with improvements in insulin sensitivity in obese patients following l-arginine supplementation. Eur J Nutr. 2014;53:387–93.

    Article  CAS  PubMed  Google Scholar 

  17. Hurt RT, Ebbert JO, Schroeder DR, et al. l-arginine for the treatment of centrally obese subjects: a pilot study. J Diet Suppl. 2014;11:40–52.

    Article  CAS  PubMed  Google Scholar 

  18. Suliburska J, Bogdanski P, Krejpcio Z, et al. The effects of l-arginine, alone and combined with vitamin C, on mineral status in relation to its antidiabetic, anti-inflammatory, and antioxidant properties in male rats on a high-fat diet. Biol Trace Elem Res. 2014;157:67–74.

    Article  CAS  PubMed  Google Scholar 

  19. Tan B, Li X, Wu Z, et al. Regulatory roles for l-arginine in reducing white adipose tissue. Front Biosci. 2012;17:2237–46.

    Article  Google Scholar 

  20. Wascher TC, Graier WF, Dittrich P, et al. Effects of low-dose l-arginine on insulin-mediated vasodilatation and insulin sensitivity. Eur J Clin Invest. 1997;27:690–5.

    Article  CAS  PubMed  Google Scholar 

  21. Piatti PM, Monti LD, Valsecchi G, et al. Long-term oral l-arginine administration improves peripheral and hepatic insulin sensitivity in type 2 diabetic patients. Diabetes Care. 2001;24:875–80.

    Article  CAS  PubMed  Google Scholar 

  22. Lucotti P, Monti L, Setola E, et al. Oral l-arginine supplementation improves endothelial function and ameliorates insulin sensitivity and inflammation in cardiopathic nondiabetic patients after an aortocoronary bypass. Metabolism. 2009;58:1270–6.

    Article  CAS  PubMed  Google Scholar 

  23. Bogdanski P, Szulinska M, Suliburska J, et al. Supplementation with l-arginine favorably influences plasminogen activator inhibitor type 1 concentration in obese patients. A randomized, double blind trial. J Endocrinol Invest. 2013;36:221–6.

    CAS  PubMed  Google Scholar 

  24. Kawano T, Nomura M, Nisikado A, et al. Supplementation of l-arginine improves hypertension and lipid metabolism but not insulin resistance in diabetic rats. Life Sci. 2003;73:3017–26.

    Article  CAS  PubMed  Google Scholar 

  25. Dyck DJ, Heigenhauser GJ, Bruce CR. The role of adipokines as regulators of skeletal muscle fatty acid metabolism and insulin sensitivity. Acta Physiol. 2006;186:5–16.

    Article  CAS  Google Scholar 

  26. Cao H. Adipocytokines in obesity and metabolic disease. J Endocrinol. 2014;220:47–59.

    Article  Google Scholar 

  27. Joffin N, Niang F, Forest C, et al. Is there NO help for leptin? Biochimie. 2012;94:2104–10.

    Article  CAS  PubMed  Google Scholar 

  28. Nisoli E, Clementi E, Paolucci C, et al. Mitochondrial biogenesis in mammals: the role of endogenous nitric oxide. Science. 2003;299:896–9.

    Article  CAS  PubMed  Google Scholar 

  29. Khedara A, Goto T, Morishima M, et al. Elevated body fat in rats by the dietary nitric oxide synthase inhibitor, L-N omega nitroarginine. Biosci Biotechnol Biochem. 1999;63:698–702.

    Article  CAS  PubMed  Google Scholar 

  30. Dai Z, Wu Z, Yang T, et al. Nitric oxide and energy metabolism in mammals. Biofactors. 2013;39:383–91.

    Article  CAS  PubMed  Google Scholar 

  31. Jobgen WS, Fried SK, Fu WJ, et al. Regulatory role for the l-arginine-nitric oxide pathway in metabolism of energy substrates. J Nutr Biochem. 2006;17:571–88.

    Article  CAS  PubMed  Google Scholar 

  32. Long YC, Zierath JR. AMP-activated protein kinase signaling in metabolic regulation. J Clin Invest. 2006;116:1776–83.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Kraemer FB, Shen WJ. Hormone-sensitive lipase: control of intracellular tri-(di)acylglycerol and cholesteryl ester hydrolysis. J Lipid Res. 2002;43:1585–94.

    Article  CAS  PubMed  Google Scholar 

  34. Lira VA, Brown DL, Lira AK, et al. Nitric oxide and ampk cooperatively regulate pgc-1 in skeletal muscle cells. J Physiol. 2010;588:3551–66.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Nisoli E, Falcone S, Tonello C, et al. Mitochondrial biogenesis by NO yields functionally active mitochondria in mammals. Proc Natl Acad Sci USA. 2004;101:16507–12.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Dillon EL, Casperson SL, Durham WJ, et al. Muscle protein metabolism responds similarly to exogenous amino acids in healthy younger and older adults during NO-induced hyperemia. Am J Physiol Regul Integr Comp Physiol. 2011;301:1408–17.

    Article  Google Scholar 

  37. Vankoningsloo S, Piens M, Lecocq C, et al. Mitochondrial dysfunction induces triglyceride accumulation in 3T3-L1 cells: role of fatty acid beta-oxidation and glucose. J Lipid Res. 2005;46:1133–49.

    Article  CAS  PubMed  Google Scholar 

  38. Lehman JJ, Barger PM, Kovacs A, et al. Peroxisome proliferator-activated receptor gamma coactivator-1 promotes cardiac mitochondrial biogenesis. J Clin Invest. 2000;106:847–56.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Karamitri A, Shore AM, Docherty K, et al. Combinatorial transcription factor regulation of the cyclic AMP-response element on the Pgc-1α promoter in white 3T3-L1 and brown HIB-1B preadipocytes. J Biol Chem. 2009;284:20738–52.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Jobgen WJ, Fu WJ, Gao H, et al. High fat feeding and dietary l-arginine supplementation differentially regulate gene expression in rat white adipose tissue. Amino Acids. 2009;3:187–98.

    Article  Google Scholar 

  41. Wu Z, Satterfield MC, Bazer FW, et al. Regulation of brown adipose tissue development and white fat reduction by l-arginine. Curr Opin Clin Nutr Metab Care. 2012;15:529–38.

    Article  CAS  PubMed  Google Scholar 

  42. Cannon B, Nedergaard J. Brown adipose tissue: function and physiological significance. Physiol Rev. 2004;84:277–359.

    Article  CAS  PubMed  Google Scholar 

  43. Tupone D, Madden CD, Morrison SF. Autonomic regulation of brown adipose tissue thermogenesis in health and disease: potential clinical applications for altering BAT thermogenesis. Front Neurosci. 2014;8:14.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Satterfield MC, Wu G. Brown adipose tissue growth and development: significance and nutritional regulation. Front Biosci (Landmark Ed). 2011;16:1589–608.

    Article  CAS  Google Scholar 

  45. Nedergaard J, Bengtsson T, Cannon B. Unexpected evidence for active brown adipose tissue in adult humans. Am J Physiol Endocrinol Metab. 2007;293:444–52.

    Article  Google Scholar 

  46. van Marken Lichtenbelt WD, Vanhommerig JW, Smulders NM, et al. Cold-activated brown adipose tissue in healthy men. N Engl J Med. 2009;360:1500–8.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Pawel Bogdanski MD, PhD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Bogdanski, P., Suliburska, J., Kręgielska-Narożna, M., Jablecka, A., Walkowiak, J. (2017). Obese Subjects and Supplemental l-Arginine. In: Patel, V., Preedy, V., Rajendram, R. (eds) L-Arginine in Clinical Nutrition. Nutrition and Health. Humana Press, Cham. https://doi.org/10.1007/978-3-319-26009-9_35

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-26009-9_35

  • Published:

  • Publisher Name: Humana Press, Cham

  • Print ISBN: 978-3-319-26007-5

  • Online ISBN: 978-3-319-26009-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics